Agios Pharm
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $19,967 | $12,880 | $12,455 | $8,726 |
Gross Profit | 19,347 | 11,201 | 9,494 | 7,641 |
EBITDA | -120,312 | -102,059 | -110,761 | -105,351 |
EBIT | -121,578 | -103,433 | -112,020 | -106,629 |
Net Income | -108,039 | -103,433 | -112,020 | -89,289 |
Net Change In Cash | 19,967 | 12,880 | 12,455 | 8,726 |
Free Cash Flow | -97,333 | -89,706 | -77,999 | -112,255 |
Cash | 89,130 | 92,710 | 80,871 | 78,964 |
Basic Shares | 58,349 | 58,139 | 57,932 | 57,459 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $54,028 | $36,498 | $26,823 | $14,240 |
Gross Profit | 47,683 | 32,333 | 17,319 | 12,536 |
EBITDA | -466,955 | -420,084 | -384,864 | -380,483 |
EBIT | -472,132 | -425,737 | -391,487 | -389,047 |
Net Income | -412,781 | 673,725 | -352,088 | -231,801 |
Net Change In Cash | 54,028 | 36,498 | 26,823 | 14,240 |
Cost of Revenue | -63,867 | |||
Free Cash Flow | -377,293 | -391,526 | -297,061 | -314,359 |
Cash | 89,130 | 76,247 | 88,205 | 139,259 |
Basic Shares | 57,972 | 57,889 | 55,651 | 54,789 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$1.85 |
2025-09-30 | -$1.78 |
2025-06-30 | -$1.93 |
2025-03-31 | -$1.55 |
